Clients News • MC Services corporate website
5522
paged,page-template-default,page,page-id-5522,paged-5,page-paged-5,bridge-core-2.1.4,qode-listing-1.0.1,qode-social-login-1.0,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode-title-hidden,paspartu_enabled,qode_grid_1400,footer_responsive_adv,qode-content-sidebar-responsive,qode-child-theme-ver-1.0.0,qode-theme-ver-20.1,qode-theme-bridge,disabled_footer_top,qode_header_in_grid,bridge-child,wpb-js-composer js-comp-ver-6.7.0,vc_responsive

CLIENT NEWS

 

 

  • InflaRx Doses First Patient in Multicenter Phase II Clinical Trial in Cutaneous Squamous Cell Carcinoma with Vilobelimab
    www.inflarx.de
  • Avisa Diagnostics Appoints Barbara Bunger, PhD as Vice President, Clinical Development
    www.avisapharma.com
  • ADOCIA presents clinical results on M1Pram at the 14th International Conference on Advanced Technologies and Treatments for Diabetes (ATTD 2021)
    www.adocia.com
  • ADOCIA Reinforces Its Board of Directors with the Appointment of Three New Independent Members
    www.adocia.com
  • APEIRON Biologics Announces Changes to Management and Supervisory Boards
    www.apeiron-biologics.com
  • MagForce AG Supports World Brain Tumor Day and Informs about Various Patient Events to Raise Awareness for One of the Deadliest Oncological Indications
    www.magforce.de
  • RedHill Biopharma Reports First Quarter 2021 Financial Results and Operational Highlights
    www.redhillbio.com
  • AFFiRiS: Positive phase 1 results with immunotherapies targeting PCSK9 to treat hypercholesterolemia published by the European Journal of Clinical Pharmacology
    www.affiris.com
  • VAXIMM to Attend International Scientific and Industry Events
    www.vaximm.com
  • RedHill Biopharma Receives Allowances for U.S. Patent Applications Covering Opaganib and RHB-107 for COVID-19
    www.redhillbio.com